What is “Entresto fatigue,” and who gets it?
“Entresto fatigue” usually means people taking Entresto (sacubitril/valsartan) report feeling unusually tired or weak. Fatigue is a known potential side effect with heart-failure medicines, and patients may also describe it when their blood pressure is running low or when their body is adjusting to the medication.
People taking Entresto are most likely to notice fatigue in the early weeks after starting, after a dose increase, or if they are also dehydrated, missing doses of other blood pressure–lowering medicines, or have illness that affects fluid balance.
How does Entresto cause fatigue (mechanisms patients can relate to)?
Entresto lowers blood pressure by blocking parts of the renin-angiotensin system. If blood pressure drops too much for someone, they can feel drained, dizzy, or weak—fatigue can be part of that picture.
Other contributors that can overlap with “fatigue” while on Entresto include:
- Low blood pressure (hypotension)
- Dehydration or reduced kidney perfusion, especially if diuretics are also used
- General heart-failure symptom fluctuation, since energy levels can change with disease stability
What other symptoms alongside fatigue should patients watch for?
Fatigue that comes with warning symptoms may signal that the dose is too high or that another issue is developing. Patients typically look out for:
- Dizziness or lightheadedness, especially when standing
- Fainting
- Worsening shortness of breath
- Swelling that suddenly worsens or weight gain that suggests fluid retention
- Signs of kidney problems (often caught through lab tests), or reduced urine output
If fatigue is severe, persistent, or paired with dizziness/fainting, patients should contact their clinician promptly rather than waiting.
When should you call a doctor about fatigue on Entresto?
Call your prescriber urgently or seek medical care if fatigue is:
- Severe or rapidly worsening
- Accompanied by fainting, chest pain, severe dizziness, or signs of very low blood pressure
- Accompanied by a sudden clinical decline in heart failure (for example, rapidly worsening breathlessness)
For less severe fatigue, it still helps to report it so the team can check blood pressure, review other medications (especially diuretics and other BP agents), and determine whether dose adjustment is needed.
Can Entresto fatigue be managed without stopping the drug?
Often, clinicians manage fatigue by adjusting the dose timing or dose itself, especially after starting or increasing therapy. Typical steps include:
- Checking home blood pressure and symptoms (including orthostatic symptoms)
- Reviewing hydration status and diuretic dose
- Ordering labs to assess kidney function and electrolytes
- Considering slower titration or dose reduction if low BP or lab changes are present
Patients generally should not stop Entresto on their own, because sudden discontinuation can worsen heart-failure control. Any changes should be coordinated with the prescribing team.
Does dose strength (or starting vs higher dose) change fatigue risk?
Fatigue is commonly noticed around titration. When people start Entresto or increase the dose, blood pressure can drop more quickly, and the body may take time to adapt. Those who already have lower baseline blood pressure, are older, or use diuretics are more likely to feel tired or weak as doses change.
How do Entresto side effects compare with similar heart-failure drugs?
Patients often compare fatigue across heart-failure therapies because several drugs can lower blood pressure or affect kidney function. Entresto (a neprilysin inhibitor plus an ARB) can cause fatigue through blood pressure effects similar to other renin-angiotensin system blockers, while diuretics commonly contribute to tiredness via dehydration or electrolyte changes.
If fatigue is the main concern, clinicians may consider alternative regimens or titration strategies within guideline therapy, depending on blood pressure, kidney function, and symptom pattern.
What questions should patients ask their cardiologist?
Useful questions include:
- Is my fatigue likely due to low blood pressure, kidney function, or another med I take?
- What blood pressure reading should trigger a dose change or a call?
- Should my diuretic dose or timing be adjusted?
- Do I need labs (kidney function/electrolytes) after dose changes?
- If fatigue continues, what dose options are available and what symptoms should improve?
Could “Entresto fatigue” be something else?
Yes. Fatigue in heart-failure patients can also be caused by anemia, infections, progression of heart failure, sleep problems, thyroid issues, medication interactions, or electrolyte disturbances. That’s why clinicians often pair symptom reports with blood pressure checks and lab work rather than assuming fatigue is only an expected side effect.
---
Sources: None provided.